ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,496 | -74.2% | 459,000 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $234,090 | -19.0% | 459,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $289,170 | -2.9% | 459,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $297,936 | -62.2% | 459,000 | 0.0% | 0.00% | -71.4% |
Q3 2022 | $789,000 | +38.7% | 459,000 | 0.0% | 0.01% | +40.0% |
Q2 2022 | $569,000 | +90.3% | 459,000 | 0.0% | 0.01% | +150.0% |
Q1 2022 | $299,000 | -40.2% | 459,000 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $500,000 | -40.2% | 459,000 | -0.1% | 0.00% | -50.0% |
Q3 2021 | $836,000 | -31.0% | 459,500 | +0.1% | 0.01% | -33.3% |
Q2 2021 | $1,212,000 | -26.6% | 459,000 | 0.0% | 0.01% | -30.8% |
Q1 2021 | $1,652,000 | +42.8% | 459,000 | 0.0% | 0.01% | +44.4% |
Q4 2020 | $1,157,000 | -0.7% | 459,000 | -0.7% | 0.01% | -18.2% |
Q3 2020 | $1,165,000 | -23.2% | 462,055 | 0.0% | 0.01% | -26.7% |
Q2 2020 | $1,516,000 | +33.9% | 462,055 | 0.0% | 0.02% | +7.1% |
Q1 2020 | $1,132,000 | -40.7% | 462,055 | +14.2% | 0.01% | -22.2% |
Q4 2019 | $1,909,000 | +46.5% | 404,500 | +32.8% | 0.02% | +38.5% |
Q3 2019 | $1,303,000 | -26.6% | 304,500 | 0.0% | 0.01% | -35.0% |
Q2 2019 | $1,775,000 | +51.5% | 304,500 | 0.0% | 0.02% | +42.9% |
Q1 2019 | $1,172,000 | +106.0% | 304,500 | 0.0% | 0.01% | +100.0% |
Q4 2018 | $569,000 | -41.6% | 304,500 | 0.0% | 0.01% | -41.7% |
Q3 2018 | $974,000 | +5.9% | 304,500 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $920,000 | -61.5% | 304,500 | -50.0% | 0.01% | -25.0% |
Q1 2018 | $2,388,000 | +89.4% | 609,000 | +100.0% | 0.02% | 0.0% |
Q4 2017 | $1,261,000 | -32.6% | 304,500 | 0.0% | 0.02% | -36.0% |
Q3 2017 | $1,870,000 | -1.3% | 304,500 | 0.0% | 0.02% | -7.4% |
Q2 2017 | $1,894,000 | -1.9% | 304,500 | 0.0% | 0.03% | -3.6% |
Q1 2017 | $1,931,000 | +18.5% | 304,500 | 0.0% | 0.03% | +16.7% |
Q4 2016 | $1,629,000 | -5.0% | 304,500 | 0.0% | 0.02% | -11.1% |
Q3 2016 | $1,714,000 | +2.5% | 304,500 | 0.0% | 0.03% | +3.8% |
Q2 2016 | $1,672,000 | -26.0% | 304,500 | 0.0% | 0.03% | -31.6% |
Q1 2016 | $2,259,000 | -10.7% | 304,500 | 0.0% | 0.04% | -9.5% |
Q4 2015 | $2,530,000 | -7.8% | 304,500 | 0.0% | 0.04% | -10.6% |
Q3 2015 | $2,744,000 | -23.8% | 304,500 | +1.5% | 0.05% | -16.1% |
Q2 2015 | $3,600,000 | +11.4% | 300,000 | 0.0% | 0.06% | +12.0% |
Q1 2015 | $3,231,000 | +112.4% | 300,000 | 0.0% | 0.05% | +108.3% |
Q4 2014 | $1,521,000 | +92.0% | 300,000 | 0.0% | 0.02% | +84.6% |
Q3 2014 | $792,000 | -34.5% | 300,000 | 0.0% | 0.01% | -35.0% |
Q2 2014 | $1,209,000 | -12.0% | 300,000 | 0.0% | 0.02% | -13.0% |
Q1 2014 | $1,374,000 | +5.5% | 300,000 | 0.0% | 0.02% | 0.0% |
Q4 2013 | $1,302,000 | +10.2% | 300,000 | 0.0% | 0.02% | +9.5% |
Q3 2013 | $1,182,000 | +86.7% | 300,000 | 0.0% | 0.02% | +75.0% |
Q2 2013 | $633,000 | +15.3% | 300,000 | 0.0% | 0.01% | +9.1% |
Q1 2013 | $549,000 | – | 300,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |